Stifel Stays on the Sidelines on WAVE Life Sciences (WVE) Ahead of the Suvodirsen DMD Readout
Tweet Send to a Friend
Stifel analyst Paul Matteis reiterated a Hold rating and $25.00 price target on WAVE Life Sciences (NASDAQ: WVE) not taking ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
